FDA Announces Collection of Information for Review by Office of Management and Budget

Summary

The Food and Drug Administration is submitting a proposed collection of information to the Office of Management and Budget for review and clearance, as required by the Paperwork Reduction Act of 1995, and is seeking public comment on the proposed guidance for formal meetings between the FDA and biosimilar biological product sponsors or applicants.